ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine.
暂无分享,去创建一个
N. Magné | A. Dubreuil | G. Milano | C. Tiffon | J. Fischel | J. Ciccolini | P. Formento | S. Marchetti | J. Formento | M. Etienne | N. Renée | N. Renée